Electromed, Inc.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy products that apply high frequency chest wall oscillation (HFCWO) therapy for pulmonary care. Its primary product is the SmartVest airway clearance system, designed for patients with compromised pulmonary functions such as bronchiectasis and cystic fibrosis, as well as neuromuscular conditions like cerebral palsy, muscular dystrophies, and amyotrophic lateral sclerosis. The portfolio includes the SmartVest SQL System, SmartVest Clearway System (which features an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose), and SmartVest Connect, a wireless technology enabling data sharing between physicians and patients. Additionally, single-patient-use SmartVest and SmartVest Wrap products are offered for acute care settings.

Electromed, Inc. is listed on the NYSE American exchange under the ticker symbol ELMD. The company's financials are reported in US Dollars (USD), as it is based in the United States.

Electromed operates in the Healthcare sector, specifically within the Medical Devices industry. The company focuses on developing and marketing airway clearance therapy products that use high frequency chest wall oscillation (HFCWO) technology to treat pulmonary conditions.

Electromed is headquartered in New Prague, Minnesota, United States. The company serves patients and healthcare providers in the United States and globally. Its products are marketed to physicians, healthcare providers, and directly to patients, addressing pulmonary care needs across various conditions.

Electromed generates revenue by selling its airway clearance therapy systems and related products. The core offering is the SmartVest line, which includes the SmartVest SQL System and SmartVest Clearway System, each comprising an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose. The company also offers SmartVest Connect, a wireless technology that allows physicians and patients to track therapy performance and collaborate on treatment decisions. Additionally, single-patient-use SmartVest and SmartVest Wrap products are sold for acute care settings. These products are marketed to physicians, healthcare providers, and directly to patients, creating multiple revenue streams from both institutional and direct-to-consumer sales.